Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States

Journal of Infection

Volumn 64, Issue 3, 2012, Pages 282-290

  Wisplinghoff, Hilmar ^a   Paulus, Tobias ^a   Lugenheim, Marianne ^a   Stefanik, Danuta ^a   Higgins, Paul G ^a   Edmond, Michael B ^b   Wenzel, Richard P ^b   Seifert, Harald ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carbapenem resistance; Intravascular catheter; Mortality; Multi drug resistance; Susceptibility

Indexed keywords

AMIKACIN; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; DOXYCYCLINE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; RIFAMPICIN; SULBACTAM; SULTAMICILLIN; TIGECYCLINE; TOBRAMYCIN;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ACINETOBACTER NOSOCOMIALIS; ACINETOBACTER PITTII; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; BROTH DILUTION; CATHETER INFECTION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HOSPITAL INFECTION; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; OUTCOME ASSESSMENT; RESPIRATORY TRACT INFECTION; SPECIES COMPARISON; UNITED STATES;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; UNITED STATES; YOUNG ADULT;

EID: 84856604549     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.12.008     Document Type: Article

References (45)

1. Boo T.W., Walsh F., Crowley B. Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3. J Med Microbiol 2009, 58:209-216.
2. Bouvet P.J., Grimont P.A. Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur Microbiol 1987, 138:569-578.
3. Brauers J., Frank U., Kresken M., Rodloff A.C., Seifert H. Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains. Clin Microbiol Infect 2005, 11:24-30.
4. Chu Y.W., Leung C.M., Houang E.T., Ng K.C., Leung C.B., Leung H.Y., et al. Skin carriage of acinetobacters in Hong Kong. J Clin Microbiol 1999, 37:2962-2967.
5. Chuang Y.C., Sheng W.H., Li S.Y., Lin Y.C., Wang J.T., Chen Y.C., et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia. Clin Infect Dis 2011, 52:352-360.
6. Cisneros J.M., Reyes M.J., Pachón J., Becerril B., Caballero F.J., García-Garmendía J.L., et al. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 1996, 22:1026-1032.
7. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement 2010, CLSI, Wayne, PA, CLSI document M100-S20.
8. Corbella X., Montero A., Pujol M., Domínguez M.A., Ayats J., Argerich M.J., et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 2000, 38:4086-4095.
9. Dijkshoorn L., Nemec A., Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007, 5:939-951.
10. Falagas M.E., Kasiakou S.K., Rafailidis P.I., Zouglakis G., Morfou P. Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy. J Antimicrob Chemother 2006, 57:1251-1254.
11. Falagas M.E., Rafailidis P.I. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Crit Care 2007, 11:134.
12. García-Garmendia J.L., Ortiz-Leyba C., Garnacho-Montero J., Jiménez-Jiménez F.J., Pérez-Paredes C., Barrero-Almodóvar A.E., et al. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin Infect Dis 2001, 33:939-946.
13. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections. Am J Infect Control 1988, 16:128-140.
14. Gerner-Smidt P., Tjernberg I., Ursing J. Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol 1991, 29:277-282.
15. Higgins P.G., Dammhayn C., Hackel M., Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010, 65:233-238.
16. Higgins P.G., Lehmann M., Wisplinghoff H., Seifert H. gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J Clin Microbiol 2010, 48:4592-4594.
17. Hoffmann M.S., Eber M.R., Laxminarayan R. Increasing resistance of Acinetobacter species to imipenem in United States hospitals, 1999-2006. Infect Control Hosp Epidemiol 2010, 31:196-197.
18. Rhomberg P.R., Jones R.N. Summary trends for the meropenem yearly susceptibility test information collection program: a 10-year experience in the United States (1999-2008). Diagn Microbiol Infect Dis 2009, 65:414-426.
19. Horrevorts A., Bergman K., Kollée L., Breuker I., Tjernberg I., Dijkshoorn L. Clinical and epidemiological investigations of Acinetobacter genomospecies 3 in a neonatal intensive care unit. J Clin Microbiol 1995, 33:1567-1572.
20. Juni E. Interspecies transformation of Acinetobacter: genetic evidence for a ubiquitous genus. J Bacteriol 1972, 112:917-931.
21. Karah N., Haldorsen B., Hegstad K., Simonsen G.S., Sundfjord A., Samuelsen O. Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. J Antimicrob Chemother 2011, 66:738-744. on behalf of the Norwegian Study Group of Acinetobacter.
22. Ko W.C., Lee N.Y., Su S.C., Dijkshoorn L., Vaneechoutte M., Wang L.R., et al. Oligonucleotide array-based identification of species in the Acinetobacter calcoaceticus-A. baumannii complex in isolates from blood cultures and antimicrobial susceptibility testing of the isolates. J Clin Microbiol 2008, 46:2052-2059.
23. Kohlenberg A., Brümmer S., Higgins P.G., Sohr D., Piening B.C., de Grahl C., et al. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. J Med Microbiol 2009, 58:1499-1507.
24. La Forgia C., Franke J., Hacek D.M., Thomson R.B., Robicsek A., Peterson L.R. Management of a multidrug-resistant Acinetobacter baumannii outbreak in an intensive care unit using novel environmental disinfection: a 38-month report. Am J Infect Control 2010, 38:259-263.
25. Lee J.H., Choi C.H., Kang H.Y., Lee J.Y., Kim J., Lee Y.C., et al. Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU. J Antimicrob Chemother 2007, 59:633-639.
26. Lim Y.M., Shin K.S., Kim J. Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates. J Clin Microbiol 2007, 45:902-905.
27. Lin Y.C., Sheng W.H., Chen Y.C., Chang S.C., Hsia K.C., Li S.Y. Differences in carbapenem resistance genes among Acinetobacter baumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan. Int J Antimicrob Agents 2010, 35:439-443.
28. Manikal V.M., Landman D., Saurina G., Oydna E., Lal H., Quale J. Endemic carbapenem-resistent Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 2000, 31:101-106.
29. Maragakis L.L., Perl T.M. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008, 46:1254-1263.
30. Marti S., Sánchez-Céspedes J., Blasco M.D., Ruiz M., Espinal P., Alba V., et al. Characterization of the carbapenem-hydrolyzing oxacillinase OXA-58 in an Acinetobacter genospecies 3 clinical isolate. Antimicrob Agents Chemother 2008, 52:2955-2958.
31. Munoz-Price L.S., Weinstein R.A. Acinetobacter infection. N Engl J Med 2008, 358:1271-1281.
32. Nemec A., Krizova L., Maixnerova M., van der Reijden T.J.K., Deschaght P., Passet V., et al. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol 2011, 162:393-404.
33. Pankey G.A. Tigecycline. J Antimicrob Chemother 2005, 56:470-480.
34. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
35. Seifert H., Dijkshoorn L., Gielen J., Nemec A., Osterhage K., Erhard M., et al. Evaluation of MALDI-TOF MS for identification of Acinetobacter species 2007, American Society for Microbiology, Washington, DC, abstr. C172, p. 113. Abstr. 107th Gen. Meet. Am. Soc. Microbiol.
36. Seifert H., Strate A., Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 1995, 74:340-349.
37. Seifert H., Strate A., Schulze A., Pulverer G. Bacteremia due to Acinetobacter species other than Acinetobacter baumannii. Infection 1994, 22:379-385.
38. Siau H., Yuen K.Y., Ho P.L., Wong S.S., Woo P.C. Acinetobacter bacteremia in Hong Kong: prospective study and review. Clin Infect Dis 1999, 28:26-30.
39. Spence R.P., Towner K.J., Henwood C.J., James D., Woodford N., Livermore D.M. Population structure and antibiotic resistance of Acinetobacter DNA group 2 and 13TU isolates from hospitals in the UK. J Med Microbiol 2002, 51:1107-1112.
40. van den Broek P.J., Arends J., Bernards A.T., de Brauwer E., Mascini E.M., van der Reijden T.J., et al. Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999-2001. Clin Microbiol Infect 2006, 12:837-843.
41. Vaneechoutte M., Dijkshoorn L., Tjernberg I., Elaichouni A., de Vos P., Claeys G., et al. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol 1995, 33:11-15.
42. Wareham D.W., Bean D.C., Khanna P., Hennessy E.M., Krahe D., Ely A., et al. Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis 2008, 27:607-612.
43. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39:309-317.
44. Wisplinghoff H., Edmond M.B., Pfaller M.A., Jones R.N., Wenzel R.P., Seifert H. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis 2000, 31:690-697.
45. Yum J.H., Yi K., Lee H., Yong D., Lee K., Kim J.M., et al. Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the blaVIM-2 gene cassettes. J Antimicrob Chemother 2002, 49:837-840.